Located on Chromosome 2, this mutation impacts GAREM2, HADHA (GRB2 associated regulator of MAPK1 subtype 2| hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; not specified